Market Overview

UPDATE: Jefferies & Company Upgrades Molina Healthcare to Hold, Raises PT

Share:
Related MOH
Senate Unveils Its Version of Trumpcare: Healthcare Stocks Up
Why Investors Should Retain Molina Healthcare (MOH) Stock

In a report published Friday, Jefferies & Company upgraded its rating on Molina Healthcare (NYSE: MOH) from Underperform to Hold, and raised its price target from $19.00 to $24.00.

Jefferies noted, “After speaking with management, we see a high probability that MOH strikes a California pricing deal, similar to HNT's, in the coming weeks. This would reduce downside risk and be well received by the market. Consequently, we are upgrading to Hold ahead of this positive catalyst. We value the benefit to MOH's profitability at $5. Importantly, without this deal, we believe the 2013 consensus is high.”

Molina Healthcare closed on Thursday at $26.41.

Latest Ratings for MOH

DateFirmActionFromTo
Jun 2017Morgan StanleyInitiates Coverage OnUnderweight
May 2017Stifel NicolausDowngradesHoldSell
May 2017Wolfe ResearchInitiates Coverage OnMarket Perform

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Upgrades Analyst Ratings

 

Related Articles (MOH)

View Comments and Join the Discussion!